Skip to main content
Caplight Logo









O7 Therapy

O7 Therapy

Private
CairoHealthcare & Life Scienceshttps://o7therapy.com

Last Round

Seed

Apr 4, 2022

Total Funding Raised

$2.1M

Company Overview

O7 Therapy operates in Healthcare & Life Sciences and is based in Cairo. Its latest recorded funding round was a Seed round in April 2022.

O7 Therapy is a healthtech company that provides a technology-enabled therapeutic platform with a network of bilingual psychiatrists and psychotherapists.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Telemedicine, Patient Engagement, HR

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Marketplace Commission

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

O7 Therapy Comparables

Compare O7 Therapy with similar companies based on industry and business-model similarity.

O7 Therapy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Arab Therapy
89%
Shezlong
88%
Labayh
87%
Book a demo to see all comparables

For institutional investors. Book with your work email.

O7 Therapy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 4, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

O7 Therapy Investors

Notable investors and investment history

O7 Therapy investors
InvestorRounds
C VenturesSeed
Hikma VenturesSeed
Lotus Venture PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 9, 2025

    Monthly visitors grew 95% MoM, reaching 24.2K.

  • May 2, 2025

    Monthly visitors increased 91% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

O7 Therapy Filings

Explore SEC and related filing metadata, where available.

O7 Therapy filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about O7 Therapy's valuation, stock price, and market status.

Is O7 Therapy a public or private company?

O7 Therapy is a private company.

What is the current stock price of O7 Therapy?

O7 Therapy is a private company, so its shares have no public market price. Caplight tracks O7 Therapy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is O7 Therapy worth (valuation)?

Valuation information for O7 Therapy is not publicly available.

Can I buy O7 Therapy stock?

O7 Therapy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was O7 Therapy's last funding round?

O7 Therapy's most recent funding round was Seed on April 4, 2022.

Who are the main investors in O7 Therapy?

Key investors in O7 Therapy include Hikma Ventures.

Will O7 Therapy IPO soon?

No public IPO plans have been announced for O7 Therapy.

How can I track O7 Therapy secondary market activity?

Caplight tracks bids, offers, and trades in O7 Therapy's shares on secondary markets.

Firmographic Details

HeadquartersCairo
Employee Range86
Year Founded2019
Last FundingApr 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?